The fact that Versius performed worse in the immediate postoperative period in terms of perceived sexual function contrasts, to some extent, with the high rate of positive surgical margins (40%), with a p-value approaching significance not in comparison with Da Vinci, but rather with Hugo RAS.
← all excerpts
Six-month outcomes of a three-arm prospective study comparing Da Vinci vs. Hugo RAS vs. versius robotic radical prostatectomy: (the COMPAR-P trial).
1
—
—